Literature DB >> 34904100

Anticoagulant treatment for pulmonary embolism in patient with cerebral hemorrhage secondary to mechanical thrombectomy: A case report.

Xiang-Ting Chen1, Qian Zhang1, Chang-Qing Zhou2, Yu-Fu Han1, Qing-Qing Cao1.   

Abstract

BACKGROUND: Cerebral hemorrhage secondary to cerebral embolism after mechanical thrombectomy is characterized by high morbidity, disability and mortality. If the patient also has severe pulmonary embolism (PE) at the same time, the treatment becomes more complex. This report describes the treatment strategy for a patient with PE and cerebral hemorrhage secondary to cerebral embolism after mechanical thrombectomy. CASE
SUMMARY: A 70-year-old woman presented to our emergency department with right-sided hemiplegia and mixed aphasia of 2.5 h duration. She was diagnosed with left cerebral embolism, left internal carotid artery occlusion, PE and left calf intramuscular vein thrombosis. Following mechanical thrombectomy, brain magnetic resonance imaging showed cerebral infarction with basal ganglia hemorrhage. We observed changes in cerebral hemorrhage on serial monitoring of brain computed tomography and adjusted the dose of anticoagulant drugs. After 3 wk of treatment, the patient's neurological and respiratory symptoms significantly improved, and a favorable prognosis was obtained.
CONCLUSION: Anticoagulation could be a potential option for PE accompanied by hemorrhagic transformation of an ischemic infarct. ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Anticoagulation; Brain embolism; Case report; Cerebral hemorrhage; Mechanical thrombectomy; Pulmonary embolism

Year:  2021        PMID: 34904100      PMCID: PMC8638063          DOI: 10.12998/wjcc.v9.i33.10279

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


Core Tip: Pulmonary embolism accompanied by cerebral hemorrhage secondary to cerebral embolism after mechanical thrombectomy is characterized by high disability and mortality. To manage this situation, we adopted a treatment strategy that involved adjustment of anticoagulant drugs according to the changes in cerebral hemorrhage after mechanical thrombectomy. The patient had a favorable prognosis.

INTRODUCTION

Cerebral hemorrhage secondary to cerebral embolism after mechanical thrombectomy is characterized by high morbidity, disability and mortality[1]. If the patient also has severe pulmonary embolism (PE) at the same time, the prognosis may be poor. In this situation, the treatment choice is critical. We report a patient with PE and cerebral hemorrhage secondary to cerebral embolism after thrombectomy who was treated with anticoagulant drugs and her neurological and respiratory symptoms significantly improved. As far as we know, this complex situation has not been described in the literature.

CASE PRESENTATION

Chief complaints

A 70-year-old woman presented to our emergency department with right-sided hemiplegia and mixed aphasia.

History of present illness

This patient had a history of pulmonary hypertension for approximately 2 mo, but her shortness of breath was not relieved. Her right-sided hemiplegia and mixed aphasia started 2.5 h ago.

History of past illness

This patient had no history of allergies, denied tobacco and alcohol use, and was healthy with no history of hypertension, diabetes, coronary heart disease, hyperlipidemia, stroke, or cardiac risk factors.

Personal and family history

This patient has no relevant family history in particular of clotting disorders.

Physical examination

On arrival, her blood pressure was 118/88 mmHg, heart rate was 93 bpm, and respiratory rate was 25 breaths/min. No pathological breath sounds or heart murmurs were noted and no edema in the lower extremities was observed. Neurological examination revealed mixed aphasia, right hemiplegia, and hypoesthesia. Right-side extremity weakness was noted and was graded 0/5 on the Medical Research Council Scale. Her National Institutes of Health Stroke Scale (NIHSS) score was 25.

Laboratory examinations

Laboratory tests revealed high levels of N-terminal pro-brain natriuretic peptide (2308 pg/mL). Her D-dimer level was also elevated (6.23 mg/L). Results of arterial blood gas analysis indicated obvious hypoxemia (PaO2, 65 mmHg; PaCO2, 36 mmHg; pH, 7.44). Protein C, protein S, antithrombin III, lupus anticoagulant, and factor V Leiden, prothrombin gene mutation as well as anti-β2-glycoprotein-1 antibodies were within normal limits. Twelve-lead electrocardiography showed a normal sinus rhythm.

Imaging examinations

Brain computed tomography angiography (CTA) showed occlusions of the intracranial segment of the left internal carotid artery and the M1 segment of the left middle cerebral artery. The Alberta Stroke Program Early CT Score was 12. Brain magnetic resonance imaging (MRI) revealed acute multiple cerebral infarctions in the bilateral centrum semiovale, left lateral ventricle, and basal ganglia (Figure 1A). Pulmonary angiography showed that both main trunks and partial branches of bilateral pulmonary arteries were embolized (Figure 2A, 2C). Digital subtraction angiography (DSA) was performed and confirmed the CT findings (Figure 1C). Transesophageal echocardiography did not show any abnormalities. Ultrasound of both lower extremities showed thrombosis in the left muscle calf venous thrombosis (MCVT).
Figure 1

MRI and digital subtraction angiography imaging before and after surgery. A: Axial brain MRI (DWI) on admission showed acute cerebral infarction in the basal ganglia; B: Postoperative brain MRI (DWI) showed subacute large areas of cerebral infarction with basal ganglia hemorrhage; C: Angiogram of the left internal carotid artery showed proximal occlusion of the left middle cerebral artery before mechanical thrombectomy; D: Postoperative angiography showed complete recanalization of the left internal carotid artery and middle cerebral artery. DWI: Diffusion-weighted imaging; MRI: Magnetic resonance imaging.

Figure 2

Changes in pulmonary embolism before and after anticoagulation. A, C: Pulmonary angiogram showed multiple repletion defects in both the pulmonary artery trunks and its branches before anticoagulation; B, D: Pulmonary angiogram showed the thrombus was eliminated after 20 d of treatment.

MRI and digital subtraction angiography imaging before and after surgery. A: Axial brain MRI (DWI) on admission showed acute cerebral infarction in the basal ganglia; B: Postoperative brain MRI (DWI) showed subacute large areas of cerebral infarction with basal ganglia hemorrhage; C: Angiogram of the left internal carotid artery showed proximal occlusion of the left middle cerebral artery before mechanical thrombectomy; D: Postoperative angiography showed complete recanalization of the left internal carotid artery and middle cerebral artery. DWI: Diffusion-weighted imaging; MRI: Magnetic resonance imaging. Changes in pulmonary embolism before and after anticoagulation. A, C: Pulmonary angiogram showed multiple repletion defects in both the pulmonary artery trunks and its branches before anticoagulation; B, D: Pulmonary angiogram showed the thrombus was eliminated after 20 d of treatment.

FINAL DIAGNOSIS

Based on these findings, she was diagnosed with left cerebral embolism, left internal carotid artery occlusion, PE, and left MCVT.

TREATMENT

Mechanical thrombectomy was performed, and a large number of thrombi were aspirated with a Penumbra ACE suction catheter, and 100 000 U urokinase was administered locally for thrombolysis. Postoperative angiography showed that the left internal carotid artery, distal middle cerebral artery, and anterior cerebral artery were recanalized (Figure 1D), and the distal blood flow was significantly improved (thrombolysis in cerebral infarction; TICI 2b). After surgery, 4000 U enoxaparin solution was administered. On the first day after surgery, the patient’s consciousness and symptoms of right hemiplegia improved (NIHSS 15 points). Postoperative brain MRI (Figure 1B) and follow-up brain CT (Figure 3A) showed that the left frontotemporal, occipital, parietal, insula, basal ganglia, and hippocampus had subacute large areas of cerebral infarction with basal ganglia hemorrhage. Anticoagulant therapy was stopped. On the second day after surgery, the follow-up CT scans showed that the cerebral hemorrhage had not enlarged markedly (Figure 3B) and the patient was given a subcutaneous injection of enoxaparin 2000 U twice daily as anticoagulant treatment. On the fourth day after surgery, brain CT scans showed that the cerebral hemorrhage had not enlarged and enoxaparin was changed to 4000 U twice daily. On day 20 after surgery, D-dimer, N-terminal pro-brain natriuretic peptide and blood gas analysis returned to normal levels. Dyspnea gradually resolved. There was no new evidence of cerebral infarction or hemorrhage on repeat CT of the brain (Figure 3C, 3D). Pulmonary angiography showed that the PE had improved (Figure 2B, 2D). Because the patient had left MCVT, combined with PE and cerebral hemorrhage, we suggest considering temporary inferior vena cava filter (IVCF) placement, but the patient’s family refused this treatment.
Figure 3

Changes on brain CT scan after surgery. A: Postprocedural brain CT showed large areas of cerebral infarction and hemorrhage in the left basal ganglia area; B–D: Follow-up brain CT showed no new evidence of cerebral infarction or hemorrhage. CT: computed tomography.

Changes on brain CT scan after surgery. A: Postprocedural brain CT showed large areas of cerebral infarction and hemorrhage in the left basal ganglia area; B–D: Follow-up brain CT showed no new evidence of cerebral infarction or hemorrhage. CT: computed tomography.

OUTCOME AND FOLLOW-UP

The patient was discharged to a rehabilitation center 3 wk after admission. The last brain CT scan showed no evidence of new cerebral infarction or hemorrhage. At the time of discharge, the patient showed slight fluid aphasia with right hemiplegia. There was right-sided upper extremity weakness graded 2/5 and lower extremity weakness graded 3/5 on the Medical Research Council Scale. Her NIHSS score was 9 and Modified Rankin Scale was 4. Dyspnea was not observed. The patient was discharged to an oral anticoagulant, namely warfarin, and no recurrence of cerebral infarction or cerebral hemorrhage was found after 6 mo of follow-up.

DISCUSSION

We present the unique case of a patient with PE and cerebral hemorrhage secondary to cerebral embolism after mechanical thrombectomy. However, after anticoagulant treatment, the neurological deficit and dyspnea symptoms gradually resolved, and the patient had a good prognosis. As far as we know, there are no similar case reports. In this study, MRI revealed that the bilateral brain showed mostly scattered lesions, and the diagnosis of multiple cerebral infarctions was made. However, neither CTA nor DSA showed obvious atherosclerotic plaques. Therefore, it is unlikely that atherosclerotic plaques were present. In addition, the patient did not have common risk factors for stroke, such as diabetes, hyperlipidemia, or hypertension[2]. She was diagnosed with pulmonary hypertension in the other hospital, but because they did not further investigate the cause, this led to subsequent aggravation of the patient’s condition. The patient had cerebral embolism and PE, and both the venous and arterial systems were affected at the same time. Therefore, the patient may have had rare causes leading to chronic PE and further pulmonary hypertension. Pulmonary hypertension may cause a brief right-to-left shunt and emboli from pulmonary arteries to enter the left heart system, finally causing paradoxical cerebral embolism[3]. Although the patient’s cardiac examination showed no abnormal passage between the right heart and left heart, abnormal passages such as patent foramen ovale may be closed or healed as the PE improves[4]. This may be related to the pressure change between the right and left atria. Based on these findings, combined with the patient’s lower extremity ultrasound, the possibility of PE caused by the left MCVT was considered. MCVT is a peripheral type of deep vein thrombosis (DVT) of the lower extremities and is considered to be the most common origin of DVT. There are related reports that MCVT can spread to the deep veins to form more serious DVT and cause chronic PE[5], or embolus may become detached and cause chronic PE[6], so we considered this possibility. At present, there is still a lack of robust evidence-based medical evidence to guide standardized treatment of MCVT; therefore, we still recommended the use of IVCFs to prevent the occurrence of another PE for this patient. It should be noted that the purpose of IVCF is to prevent PE and therefore to reduce associated morbidity and mortality, although randomized trials are needed[7,8]. In patients undergoing anticoagulation for DVT or PE in whom a contraindication to anticoagulation develops, many guidelines and expert consensus suggest[9] that an IVCF be considered in the setting of ongoing significant clinical risk for PE. Furthermore, we have not found the cause of venous thrombosis, so rare causes of venous thrombosis could not be excluded[10]. This patient had a large area of cerebral embolism caused by acute occlusion of the internal carotid artery and was treated with emergency mechanical thrombectomy. Postoperative CT showed hemorrhagic transformation of an ischemic infarct. However, the patient also had multiple emboli in both pulmonary aortic trunks, and both blood gas analysis and dyspnea indicated severe PE. Anticoagulation is indicated for the treatment of PE[11], but it may aggravate cerebral hemorrhage. However, if anticoagulation is not administered, PE may gradually worsen and threaten the patient’s life. Furthermore, the recanalized blood vessel may be occluded again. Cerebral hemorrhage secondary to mechanical thrombectomy is not always aggravated after anticoagulation[12,13], and PE would not improve without anticoagulation. Therefore, the following treatment strategy was adopted. On the first day after surgery, brain CT scan showed hemorrhage in the left basal ganglia area and anticoagulant treatment was stopped. On the second day after surgery, a half-dose of low-molecular-weight heparin was administered twice daily. To adjust the dose of anticoagulant drugs, consecutive brain CT examinations were performed to observe whether the cerebral hemorrhage was progressively aggravated. On the fifth day after surgery, when half-dose anticoagulation therapy did not aggravate cerebral hemorrhage, a full dose was administered. The patient’s neurological symptoms and respiratory symptoms subsequently showed significant improvement.

CONCLUSION

It is unlikely that a specific treatment regimen will work for all patients. In patients with PE combined with cerebral embolism, especially those with cerebral hemorrhage secondary to mechanical thrombectomy, the benefit of anticoagulation and the risk of bleeding should be carefully evaluated to implement an individualized treatment strategy. Disease evolution should be closely monitored to adjust the treatment strategy at any time.
  13 in total

1.  Clinical Effectiveness and Safety Outcomes of Endovascular Treatment for Acute Anterior Circulation Ischemic Stroke in China.

Authors:  Wenjie Zi; Huaiming Wang; Dong Yang; Yonggang Hao; Meng Zhang; Yu Geng; Min Lin; Yue Wan; Zhonghua Shi; Zhiming Zhou; Wei Wang; Haowen Xu; Xiguang Tian; Penghua Lv; Shuiping Wang; Wenhua Liu; Zhen Wang; Xintong Liu; Fuqiang Guo; Dequan Zheng; Hua Li; Mingyi Tu; Ping Jin; Guodong Xiao; Yuxiu Liu; Gelin Xu; Yunyun Xiong; Xinfeng Liu
Journal:  Cerebrovasc Dis       Date:  2017-08-26       Impact factor: 2.762

2.  Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.

Authors:  Tze-Fan Chao; Gregory Y H Lip; Chia-Jen Liu; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Jo-Nan Liao; Fa-Po Chung; Tzeng-Ji Chen; Shih-Ann Chen
Journal:  J Am Coll Cardiol       Date:  2018-01-16       Impact factor: 24.094

3.  Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage.

Authors:  Maximilian I Sprügel; Jochen A Sembill; Joji B Kuramatsu; Stefan T Gerner; Manuel Hagen; Sebastian S Roeder; Matthias Endres; Karl Georg Haeusler; Jan Sobesky; Johannes Schurig; Sarah Zweynert; Miriam Bauer; Peter Vajkoczy; Peter Arthur Ringleb; Jan Christoph Purrucker; Timolaos Rizos; Jens Volkmann; Wolfgang Muellges; Peter Kraft; Anna-Lena Schubert; Frank Erbguth; Martin Nueckel; Peter D Schellinger; Jörg Glahn; Ulrich J Knappe; Gereon Rudolf Fink; Christian Dohmen; Henning Stetefeld; Anna Lena Fisse; Jens Minnerup; Georg Hagemann; Florian Rakers; Heinz Reichmann; Hauke Schneider; Sigrid Wöpking; Albert C Ludolph; Sebastian Stösser; Hermann Neugebauer; Joachim Röther; Peter Michels; Michael Schwarz; Gernot Reimann; Hansjörg Bäzner; Henning Schwert; Joseph Classen; Dominik Michalski; Armin Grau; Frederick Palm; Christian Urbanek; Johannes C Wöhrle; Fahid Alshammari; Markus Horn; Dirk Bahner; Otto W Witte; Albrecht Guenther; Gerhard F Hamann; Hannes Lücking; Arnd Dörfler; Stefan Schwab; Hagen B Huttner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-04-16       Impact factor: 10.154

4.  Elderly patients with intertrochanteric fractures after intramedullary fixation : Analysis of risk factors for calf muscular vein thrombosis.

Authors:  Hao Su; Hongzhi Liu; Juan Liu; Xin Wang
Journal:  Orthopade       Date:  2018-04       Impact factor: 1.087

5.  Isolated calf muscular vein thrombosis is associated with pulmonary embolism and a high incidence of additional ipsilateral and contralateral deep venous thrombosis.

Authors:  Marcus R Kret; Timothy K Liem; Erica L Mitchell; Gregory J Landry; Gregory L Moneta
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2012-12-08

6.  Embolic strokes of undetermined source: the case for a new clinical construct.

Authors:  Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly
Journal:  Lancet Neurol       Date:  2014-04       Impact factor: 44.182

7.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).

Authors:  Stavros V Konstantinides; Guy Meyer; Cecilia Becattini; Héctor Bueno; Geert-Jan Geersing; Veli-Pekka Harjola; Menno V Huisman; Marc Humbert; Catriona Sian Jennings; David Jiménez; Nils Kucher; Irene Marthe Lang; Mareike Lankeit; Roberto Lorusso; Lucia Mazzolai; Nicolas Meneveau; Fionnuala Ní Áinle; Paolo Prandoni; Piotr Pruszczyk; Marc Righini; Adam Torbicki; Eric Van Belle; José Luis Zamorano
Journal:  Eur Heart J       Date:  2020-01-21       Impact factor: 35.855

8.  An Approach to Working Up Cases of Embolic Stroke of Undetermined Source.

Authors:  Sookyung Ryoo; Jong-Won Chung; Mi Ji Lee; Suk Jae Kim; Jin Soo Lee; Gyeong-Moon Kim; Chin-Sang Chung; Kwang Ho Lee; Ji Man Hong; Oh Young Bang
Journal:  J Am Heart Assoc       Date:  2016-03-22       Impact factor: 5.501

9.  Association of Inferior Vena Cava Filter Placement for Venous Thromboembolic Disease and a Contraindication to Anticoagulation With 30-Day Mortality.

Authors:  Tyson E Turner; Mohammed J Saeed; Eric Novak; David L Brown
Journal:  JAMA Netw Open       Date:  2018-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.